---
figid: PMC5362636__fbioe-05-00017-g002
figtitle: Possible interplay between insulin-like growth factor (IGF)-1 and vascular
  endothelial growth factor (VEGF) receptor signaling pathways
organisms:
- Gallus gallus
- Dipturus trachyderma
- Uria aalge
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Capra hircus
- Homo sapiens
- Vicia sativa
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Capra hircus
- Gallus gallus
- Mus musculus
- Danio rerio
pmcid: PMC5362636
filename: fbioe-05-00017-g002.jpg
figlink: /pmc/articles/PMC5362636/figure/F2/
number: F2
caption: (A) Possible interplay between insulin-like growth factor (IGF)-1 and vascular
  endothelial growth factor (VEGF) receptor signaling pathways. They equally converge
  on ERK kinase, which fine-tune the activity of the main osteogenic transcription
  factor Runx2. IGF1 and VEGF also trigger PI3/AKT signaling pathway that can induce
  vasculogenesis or beta-catenin phosphorylation. On the contrary, non-phosphorylated
  beta-catenin acts as a pro-osteogenic factor regulating Runx2 and other genes. (B)
  consequences of IGF1 or IGF1/VEGF treatment on skin-derived multipotent stromal
  cells (S-MSCs) gene expression suggesting their commitment toward the endothelial
  phenotype. (C) Consequences of IGF1 or IGF1/VEGF treatment on PDPCs showing their
  main commitment toward the osteoblastic phenotype. Continuous lines indicate a marked
  effect, while dotted lines suggest a weaker regulation. Modified from Ferretti et
  al. ().
papertitle: 'Biofabrication and Bone Tissue Regeneration: Cell Source, Approaches,
  and Challenges.'
reftext: Monia Orciani, et al. Front Bioeng Biotechnol. 2017;5:17.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7839639
figid_alias: PMC5362636__F2
figtype: Figure
redirect_from: /figures/PMC5362636__F2
ndex: e33bb51b-df2b-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5362636__fbioe-05-00017-g002.html
  '@type': Dataset
  description: (A) Possible interplay between insulin-like growth factor (IGF)-1 and
    vascular endothelial growth factor (VEGF) receptor signaling pathways. They equally
    converge on ERK kinase, which fine-tune the activity of the main osteogenic transcription
    factor Runx2. IGF1 and VEGF also trigger PI3/AKT signaling pathway that can induce
    vasculogenesis or beta-catenin phosphorylation. On the contrary, non-phosphorylated
    beta-catenin acts as a pro-osteogenic factor regulating Runx2 and other genes.
    (B) consequences of IGF1 or IGF1/VEGF treatment on skin-derived multipotent stromal
    cells (S-MSCs) gene expression suggesting their commitment toward the endothelial
    phenotype. (C) Consequences of IGF1 or IGF1/VEGF treatment on PDPCs showing their
    main commitment toward the osteoblastic phenotype. Continuous lines indicate a
    marked effect, while dotted lines suggest a weaker regulation. Modified from Ferretti
    et al. ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IGF1
  - FCGR1A
  - FCGR1BP
  - FCGR1CP
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - CTNNB1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - RUNX2
  - BMP2
  - PECAM1
  - CD34
  - MMP13
  - NIN
  - Vegfa
  - Igf1
  - Igf1r
  - Akt1
  - Ephb1
  - Ctnnb1
  - Runx2
  - Bmp2
  - Gprasp1
  - Pecam1
  - Cd34
  - Mmp13
  - Nin
  - IGF1R
  - CTNND1
  - Ephb2
  - Mapk1
  - Bmpr2
  - vegfaa
  - igf1
  - ctnnb1
  - bmp2b
  - pecam1a
  - cd34
  - mmp13a
  - nin
  - Cancer
---
